Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors

Author:

Deng Hongfeng1,Zhou Jingye1,Sundersingh Flora1,Messer Jeffrey A.1,Somers Donald O.2,Ajakane Myriam3,Arico-Muendel Christopher C.1,Beljean Arthur2,Belyanskaya Svetlana L.1,Bingham Ryan2,Blazensky Emily4,Boullay Anne-Benedicte3,Boursier Eric3,Chai Jing1,Carter Paul2,Chung Chun-Wa2,Daugan Alain3,Ding Yun1,Herry Kenny3,Hobbs Clare2,Humphries Eric4,Kollmann Christopher1,Nguyen Van Loc3,Nicodeme Edwige3,Smith Sarah E.2,Dodic Nerina3,Ancellin Nicolas3

Affiliation:

1. Platform of Technology and Science, GlaxoSmithKline, 830 Winter Street, Waltham, Massachusetts 02451, United States

2. Medicines Research Centre, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, U.K.

3. Centre de Recherche, GlaxoSmithKline, Les Ulis, 25,27 Avenue du Québec, 91140 Villebon sur Yvette, France

4. Chemistry Department, Northeastern University, Boston, Massachusetts 02115, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3